MSCI World ETF Caught Between a Mega-IPO and a Narrowing Market

Broadcom's post-earnings rout and SpaceX's forced index inclusion highlight the heavy US tech tilt in the iShares MSCI World ETF, raising questions about global diversification.

The iShares MSCI World ETF bills itself as a global diversification play, but the past week has exposed just how thin that veneer can be. A single chipmaker’s post-earnings rout and the looming forced purchase of SpaceX shares are pulling the fund in opposite directions — and raising questions about what “broad market” really means in today’s index-driven world.

Broadcom’s Fall Highlights a Top-Heavy Reality

When Broadcom reported quarterly revenue of $22.187 billion — up 48% year-on-year, with its AI division contributing $10.8 billion — and guided for $29.4 billion in the current quarter, there was nothing obviously wrong. Yet the stock cratered by more than 14% on June 4. The culprit: expectations had been set even higher.

The knock-on effect was immediate for the MSCI World ETF. Broadcom, with a 2.40% weighting, ranks among the fund’s top five holdings, alongside Nvidia (5.70%), Apple (5.12%), Microsoft (3.45%) and Amazon (2.75%). That cluster of five names — all in US information technology — now drives the daily performance. The tech sector alone accounts for 31.43% of the portfolio, and the United States represents 72.40% of the geographic allocation. On the day of the Broadcom slide, the MSCI world index eked out a gain of just 0.06%, while the Dow and S&P 500 posted modest advances and the Nasdaq slipped. The ETF closed at $205.67, with a 30-day return of 2.51% and an annualized volatility of 10.82%.

Any attempt to escape this concentration by switching to an all-country fund offers only marginal relief. The iShares MSCI ACWI ETF, with 2,270 holdings, still gave Broadcom a 1.55% weight. The SPDR Portfolio MSCI Global Stock Market ETF, at 2,933 positions, weighed it at 1.63%. Emerging markets and smaller caps soften the blow, but the central problem — heavy dependence on a handful of US tech giants — remains common to almost every developed-market ETF.

SpaceX Forces the Index Hand

This structural tilt is about to become more pronounced. On June 12, SpaceX is expected to debut on the Nasdaq at $135 per share, selling 555.6 million shares for a total raise of $75 billion and a valuation of $1.77 trillion — placing it ahead of Tesla among US companies. MSCI CEO Henry Fernandez has already signaled that the index provider could add SpaceX to its benchmarks as soon as ten trading days after the listing, waiving the standard three-month holding period for unusually large new issues. The Nasdaq itself changed its rules in May to allow mega-cap IPOs into the Nasdaq 100 after just 15 trading days.

Because the MSCI World ETF passively tracks its index, it will be forced to buy. Analysts estimate the resulting buying pressure from index funds could reach $12 billion, and with roughly 70% of the ETF’s assets in US equities, a substantial chunk of that flow will land squarely in this fund. Goldman Sachs and Bank of America have already scrapped any expectation of Federal Reserve rate cuts this year — the fed funds rate sits at 3.5%–3.75%, and inflation has climbed to a three-year high of 3.8% — meaning the monetary backdrop offers no relief for richly valued tech stocks. The ETF trades at a price-to-earnings ratio of 26.34 and a price-to-book of 4.09, with a year-to-date gain of 10.57%.

Jobs Data Reinforces the Fed Pause

The May employment report, due on Friday, is expected to show 80,000 new nonfarm payrolls, down from 115,000 in April, with unemployment holding at 4.3%. ADP’s private-sector reading of 122,000 was the strongest since January. A resilient labour market all but locks in a hold at the Federal Reserve’s June 16–17 meeting; fed funds futures price a 97% probability of no change. That puts additional pressure on the stretched valuations of the ETF’s biggest components, since higher rates reduce the present value of distant earnings — a dynamic to which tech stocks are especially sensitive.

Pharma Tariffs Add a Sector-Level Drag

Meanwhile, the health-care segment — roughly 10% of the fund — is absorbing new US tariffs: a 15% levy on patented pharmaceuticals from the European Union, Japan, South Korea and Switzerland, plus a 10% duty on British products. Companies without existing pricing agreements face potential duties of up to 100%. FactSet has already trimmed earnings forecasts for the sector.

Morningstar rates the iShares MSCI World ETF with its highest confidence score, Gold, among 297 peer funds. Its 0.24% expense ratio is higher than some rivals (Invesco charges 0.05%), but net inflows over the past twelve months still reached $1.86 billion. The fund has been a reliable vehicle for global equity exposure. The question now is whether that vehicle is becoming too tightly tethered to a handful of US tech winners — and whether the forced addition of a $1.77 trillion rocket company will tighten those bonds further.